SB 1042 Hawaii Senate · 2026 Regular Session

RELATING TO MENTAL HEALTH.

Summary

Establishes a two-year Mental Health Emerging Therapies Pilot Program within the Office of Wellness and Resilience. Appropriates funds. Effective 7/1/3000. (HD1)

Issues: ✓ Healthcare

Bill status passed both 4 of 5 stages cleared

Introduction

Jan 2025

Committee Review

Apr 2025

Senate Passage

Feb 2025

House Passage

Apr 2025

Governor

Introduced Jan 17, 2025 Last action Apr 2, 2026

Maddy AI version diff · 2 comparisons

What changed between versions

SB1042_HD1 → SB1042_SD1 · 7 edits

MODERATE

The bill was revised to shift from a temporary pilot program within the Office of Wellness and Resilience to a permanent special fund administered by the Department of Health. The changes expand the scope to explicitly include FDA breakthrough therapies, clarify definitions for 'emerging therapies' and 'compassionate use,' and update the effective date to December 31, 2050.

Scope change

The bill's scope changed from a two-year pilot program limited to the Office of Wellness and Resilience to a standing special fund administered by the Department of Health with a permanent expiration date.

SCOPE

The program changed from a two-year pilot to a permanent special fund that does not automatically expire in 2027.

ELIGIBILITY

The administering agency changed from the Office of Wellness and Resilience to the Department of Health.

FISCAL

The fund now explicitly includes appropriations, gifts, donations, grants, and interest earned as sources of money.

DEFINITION

New definitions were added for 'compassionate use' and 'United States Food and Drug Administration breakthrough therapies'.

REQUIREMENT

Reporting requirements were updated to require annual reports to the legislature starting with the 2026 session, rather than just for 2026 and 2027.

The Department of Health is now required to adopt rules pursuant to Chapter 91, whereas the previous version allowed the office to adopt rules without regard to that chapter.

TIMELINE

The effective date of the Act was changed from July 1, 3000, to December 31, 2050.

Floor votes

How they voted

This bill passed the Senate by voice vote (no roll call recorded).

Full legislative history

Actions timeline

Total actions

Key actions

Committee

Amendments

Apr 25, 2025

Upper · Passed

Conference committee meeting to reconvene on 04-25-25 5:20 PM; Conference Room 329.

upper

Apr 24, 2025

Upper · Passed

Conference committee meeting scheduled for 04-25-25 3:15PM; Conference Room 329.

upper

Apr 10, 2025

Amended

Senate disagrees with House amendments.

upper

Apr 10, 2025

Introduced

Received from House (Hse. Com. No. 668).

upper

Apr 8, 2025

Lower · Passed

Passed Third Reading with none voting aye with reservations; Representative(s) Kila, Kitagawa, Lamosao, Matayoshi, Pierick voting no (5) and Representative(s) Cochran, Marten excused (2). Transmitted to Senate.

lower

Apr 2, 2025

Lower · Passed

The committee on FIN recommend that the measure be PASSED, UNAMENDED. The votes were as follows: 15 Ayes: Representative(s) Yamashita, Takenouchi, Grandinetti, Holt, Hussey, Keohokapu-Lee Loy, Kitagawa, Kusch, Lamosao, Lee, M., Miyake, Morikawa, Templo, Alcos, Reyes Oda; Ayes with reservations: none; Noes: none; and Excused: none.

lower

Mar 18, 2025

Committee

Reported from HLT (Stand. Com. Rep. No. 1312) as amended in HD 1, recommending passage on Second Reading and referral to FIN.

lower

Mar 14, 2025

Lower · Passed

The committee on HLT recommend that the measure be PASSED, WITH AMENDMENTS. The votes were as follows: 9 Ayes: Representative(s) Takayama, Keohokapu-Lee Loy, Amato, Chun, Marten, Olds, Takenouchi, Alcos, Garcia; Ayes with reservations: none; 0 Noes: none; and 0 Excused: none.

lower

Mar 4, 2025

Committee

Referred to HLT, FIN, referral sheet 18

lower

Feb 28, 2025

Introduced

Received from Senate (Sen. Com. No. 50) in amended form (SD 1).

lower

Feb 28, 2025

Upper · Passed

Report Adopted; Passed Third Reading. Ayes, 22; Aye(s) with reservations: Senator(s) McKelvey. Noes, 1 (Senator(s) Awa). Excused, 2 (Senator(s) Fukunaga, Kidani). Transmitted to House.

upper

Feb 19, 2025

Upper · Passed

The committee(s) on WAM recommend(s) that the measure be PASSED, UNAMENDED. The votes in WAM were as follows: 13 Aye(s): Senator(s) Dela Cruz, Moriwaki, Aquino, DeCoite, Elefante, Hashimoto, Inouye, Kanuha, Kidani, Kim, Lee, C., Wakai, Fevella; Aye(s) with reservations: none ; 0 No(es): none; and 0 Excused: none.

upper

Feb 14, 2025

Upper · Passed

The committee(s) on WAM will hold a public decision making on 02-19-25 10:02AM; Conference Room 211 & Videoconference.

upper

Feb 14, 2025

Upper · Passed

Report adopted; Passed Second Reading, as amended (SD 1) and referred to WAM.

upper

Feb 14, 2025

Committee

Reported from HHS (Stand. Com. Rep. No. 625) with recommendation of passage on Second Reading, as amended (SD 1) and referral to WAM.

upper

Feb 12, 2025

Upper · Passed

The committee(s) on HHS recommend(s) that the measure be PASSED, WITH AMENDMENTS. The votes in HHS were as follows: 5 Aye(s): Senator(s) San Buenaventura, Aquino, Hashimoto, Keohokalole, Fevella; Aye(s) with reservations: none ; 0 No(es): none; and 0 Excused: none.

upper

Feb 7, 2025

Upper · Passed

The committee(s) on HHS has scheduled a public hearing on 02-12-25 1:00PM; Conference Room 225 & Videoconference.

upper

Jan 23, 2025

Committee

Referred to HHS, WAM.

upper

Jan 17, 2025

Introduced

Introduced.

upper

2 primary · 0 co-sponsors